DNMT3A and myelodysplastic syndrome: Some studies have reported that in MDS patients, DNMT3A mutations were associated with a higher risk of leukemia transformation and shorter OS, but no specific study describing either phenotypic or survival associations was exclusively performed in MDS-5q patients [49,50].